Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.
Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.
复制标题
DOI:
10.1001/jamaneurol.2021.3821
复制
发表时间:
2021-12-01
期刊:
影响因子:
29
通讯作者:
Wilson MR
中科院分区:
文献类型:
--
作者:
Bartley CM;Johns C;Ngo TT;Dandekar R;Loudermilk RL;Alvarenga BD;Hawes IA;Zamecnik CR;Zorn KC;Alexander JR;Wapniarski AE;DeRisi JL;Francisco C;Nash KB;Wietstock SO;Pleasure SJ;Wilson MR
Are anti–SARS-CoV-2 or antineural antibodies present in the cerebrospinal fluid of pediatric patients with COVID-19 and neuropsychiatric symptoms? In this case series of 3 pediatric patients with subacute neuropsychiatric impairment, 2 had intrathecal anti–SARS-CoV-2 antibodies as well as intrathecal antineural antibodies. Anti–transcription factor 4 (TCF4) autoantibodies in one patient who responded to immunotherapy were validated. A subset of pediatric patients with COVID-19 and subacute neuropsychiatric symptoms have intrathecal antineural autoantibodies, suggesting central nervous system autoimmunity in pediatric patients with COVID-19 and recent neuropsychiatric symptoms. This case series examines whether anti–SARS-CoV-2 and autoreactive antibodies are present in the cerebrospinal fluid (CSF) of pediatric patients with COVID-19 and subacute neuropsychiatric dysfunction. Neuropsychiatric manifestations of COVID-19 have been reported in the pediatric population. To determine whether anti–SARS-CoV-2 and autoreactive antibodies are present in the cerebrospinal fluid (CSF) of pediatric patients with COVID-19 and subacute neuropsychiatric dysfunction. This case series includes 3 patients with recent SARS-CoV-2 infection as confirmed by reverse transcriptase–polymerase chain reaction or IgG serology with recent exposure history who were hospitalized at the University of California, San Francisco Benioff Children’s Hospital and for whom a neurology consultation was requested over a 5-month period in 2020. During this period, 18 total children were hospitalized and tested positive for acute SARS-CoV-2 infection by reverse transcriptase–polymerase chain reaction or rapid antigen test. Detection and characterization of CSF anti–SARS-CoV-2 IgG and antineural antibodies. Of 3 included teenaged patients, 2 patients had intrathecal anti–SARS-CoV-2 antibodies. CSF IgG from these 2 patients also indicated antineural autoantibodies on anatomic immunostaining. Autoantibodies targeting transcription factor 4 (TCF4) in 1 patient who appeared to have a robust response to immunotherapy were also validated. Pediatric patients with COVID-19 and prominent subacute neuropsychiatric symptoms, ranging from severe anxiety to delusional psychosis, may have anti–SARS-CoV-2 and antineural antibodies in their CSF and may respond to immunotherapy.
登录
查看更多内容
DOI:
10.1016/j.xcrm.2020.100123
发表时间:
2020-10-20
期刊:
Cell reports. Medicine
影响因子:
--
作者:
Zamecnik CR;Rajan JV;Yamauchi KA;Mann SA;Loudermilk RP;Sowa GM;Zorn KC;Alvarenga BD;Gaebler C;Caskey M;Stone M;Norris PJ;Gu W;Chiu CY;Ng D;Byrnes JR;Zhou XX;Wells JA;Robbiani DF;Nussenzweig MC;DeRisi JL;Wilson MR
通讯作者:
Wilson MR
DOI:
10.1016/s2215-0366(20)30462-4
发表时间:
2021-03
期刊:
The lancet. Psychiatry
影响因子:
--
作者:
Taquet M;Luciano S;Geddes JR;Harrison PJ
通讯作者:
Harrison PJ
影响因子:
3.7
作者:
Miao W;Man F;Wu S;Lv B;Wang Z;Xian J;Sabel BA;He H;Jiao Y
通讯作者:
Jiao Y
影响因子:
6.8
作者:
Teixeira JR;Szeto RA;Carvalho VMA;Muotri AR;Papes F
通讯作者:
Papes F
DOI:
10.1212/nxi.0000000000000893
发表时间:
2020-11
期刊:
Neurology(R) neuroimmunology & neuroinflammation
影响因子:
--
作者:
Alexopoulos H;Magira E;Bitzogli K;Kafasi N;Vlachoyiannopoulos P;Tzioufas A;Kotanidou A;Dalakas MC
通讯作者:
Dalakas MC